| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 719 | 2021 |
| Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ... The Lancet 394 (10197), 478-487, 2019 | 397 | 2019 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 393 | 2022 |
| The clinical approach toward giant cell tumor of bone L Van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ... The oncologist 19 (5), 550-561, 2014 | 294 | 2014 |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 293 | 2021 |
| Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas VM van Praag, AJ Rueten-Budde, V Ho, PDS Dijkstra, IC van der Geest, ... Surgical oncology 27 (3), 402-408, 2018 | 175 | 2018 |
| Higher incidence rates than previously known in tenosynovial giant cell tumors: A nationwide study in The Netherlands MJL Mastboom, FGM Verspoor, AJ Verschoor, D Uittenbogaard, ... Acta orthopaedica 88 (6), 688-694, 2017 | 162 | 2017 |
| Intercalary allograft reconstructions following resection of primary bone tumors: a nationwide multicenter study MPA Bus, PDS Dijkstra, MAJ Van de Sande, AHM Taminiau, ... JBJS 96 (4), e26, 2014 | 157 | 2014 |
| Comparison between tripod and skin-fixed recording of scapular motion CGM Meskers, MAJ Van de Sande, JH De Groot Journal of biomechanics 40 (4), 941-946, 2007 | 151 | 2007 |
| LUMiC® Endoprosthetic Reconstruction After Periacetabular Tumor Resection: Short-term Results MPA Bus, A Szafranski, S Sellevold, T Goryn, PC Jutte, JAM Bramer, ... Clinical Orthopaedics and Related Research® 475, 686-695, 2017 | 143 | 2017 |
| Proximal humerus reconstruction after tumour resection: biological versus endoprosthetic reconstruction MAJ van de Sande, PDS Dijkstra, AHM Taminiau International orthopaedics 35, 1375-1380, 2011 | 135 | 2011 |
| Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts S Stacchiotti, AB Miah, AM Frezza, C Messiou, C Morosi, A Caraceni, ... ESMO open 6 (3), 100170, 2021 | 134 | 2021 |
| Treatment of pathological fractures of the long bones JJ Willeumier, YM van der Linden, MAJ van de Sande, PDS Dijkstra EFORT Open Reviews 1 (5), 136-145, 2016 | 132 | 2016 |
| What Are the Long-term Results of MUTARS® Modular Endoprostheses for Reconstruction of Tumor Resection of the Distal Femur and Proximal Tibia? MPA Bus, MAJ van de Sande, M Fiocco, GR Schaap, JAM Bramer, ... Clinical Orthopaedics and Related Research® 475, 708-718, 2017 | 130 | 2017 |
| Pathological muscle activation patterns in patients with massive rotator cuff tears, with and without subacromial anaesthetics F Steenbrink, JH de Groot, HEJ Veeger, CGM Meskers, ... Manual therapy 11 (3), 231-237, 2006 | 127 | 2006 |
| Poor long-term clinical results of saddle prosthesis after resection of periacetabular tumors JA Jansen, MAJ Van de Sande, PDS Dijkstra Clinical Orthopaedics and Related Research® 471 (1), 324-331, 2013 | 125 | 2013 |
| Giant cell tumor with pathologic fracture: should we curette or resect? L van der Heijden, PDS Dijkstra, DA Campanacci, CLMH Gibbons, ... Clinical Orthopaedics and Related Research® 471, 820-829, 2013 | 119 | 2013 |
| Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study MJL Mastboom, E Palmerini, FGM Verspoor, AJ Rueten-Budde, ... The Lancet Oncology 20 (6), 877-886, 2019 | 114 | 2019 |
| Outcome of advanced, unresectable conventional central chondrosarcoma AM van Maldegem, H Gelderblom, E Palmerini, SD Dijkstra, M Gambarotti, ... Cancer 120 (20), 3159-3164, 2014 | 112 | 2014 |
| A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: personalised sarcoma care (PERSARC) VM van Praag, AJ Rueten-Budde, LM Jeys, MK Laitinen, R Pollock, ... European Journal of Cancer 83, 313-323, 2017 | 104 | 2017 |
Hans GelderblomLUMCยืนยันอีเมลแล้วที่ lumc.nl